AC
MACK

Aristides Capital’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Aristides Capital’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,000
Closed -$148K – 345
2024
Q1 		$148K Buy
+10,000
New +$148K 0.05% 223